Tiotropium and fluticasone inhibit rhinovirus-induced mucin production via multiple mechanisms in differentiated airway epithelial cells Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020
Fluticasone propionate reduces bacterial airway epithelial invasion Source: Eur Respir J 2008; 32: 1283-1288 Year: 2008
Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression Source: Eur Respir J 2001; 18: 139-145 Year: 2001
The effect of salmeterol/fluticasone propionate (SFC) on bronchial mucosal neutrophils and IL-8 gene expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 354s Year: 2007
Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells Source: Eur Respir J 2012; 39: 439-445 Year: 2012
Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells Source: Eur Respir J 2012; 40: 122-132 Year: 2012
Budesonide esterification in human bronchial epithelial cells is not impaired by formoterol Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002
Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004
Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011
Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Guaifenesin suppresses MUC5AC content and secretion in human airway epithelial cell cultures: Comparison with N-acetylcysteine and ambroxol Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012
Nasal fibroblast functions involved in airway inflammation and remodelling are downregulated by fluticasone propionate (FP) Source: Eur Respir J 2001; 18: Suppl. 33, 147s Year: 2001
IP-10 decreases TNFα-induced mucin secretion in airway epithelial cell Source: Eur Respir J 2006; 28: Suppl. 50, 827s Year: 2006
Investigating the effects of interleukin-33 on rhinovirus A induced changes in asthmatic bronchial epithelial cells Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
CC chemokine receptor 3 inhibitor, antileukinate, suppressed ovalbumin induced goblet cell metaplasia and airway hyperresponsiveness in mice Source: Annual Congress 2005 - Basic mechanisms in asthma and COPD: new insights Year: 2005
Effect of beclomethasone dipropionate, formoterol and their combination on TNF-α-induced ICAM-1 and IL-8 expression in human bronchial epithelial cells Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Inhibitory activities of fluticasone propionate and salmeterol on airway epithelial cell functions (FLIC24): adhesion molecule expression and cytokine release Source: Eur Respir J 2001; 18: Suppl. 33, 246s Year: 2001
IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung Year: 2013